The American pharmaceutical company Moderna reported this Monday that its Covid-19 vaccine works against the variants identified in the United Kingdom and South Africa after analysing the serum of people vaccinated against the disease in the laboratory.
"We are encouraged by this new data, which reinforces our confidence that the Moderna Covid-19 vaccine should protect against these newly detected variants," said Stephane Bancel, CEO of Moderna.
Even so, the company has stated that it will continue working on the vaccine to further increase protection against the strains, especially for the South African variant, which is the one with the highest resistance in the study.
Also this Monday, the Pasteur Institute of France announced that it is abandoning its main vaccine project against the coronavirus, since the first trials showed that it is less effective than expected, reports AFP.
"Induced immune responses have been lower than those seen in people cured of a natural infection and those seen with licensed vaccines," explained the Institute to justify its decision.
Pasteur's project was based on the measles vaccine that had been adapted to combat SARS-CoV-2. To develop and distribute it, the prestigious research institute had partnered with the pharmaceutical company MSD.